These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2672262

  • 21. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM, Maskell JP, Sehgal SC, Williams JD.
    Infection; 1989; 17(3):165-7. PubMed ID: 2737760
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antibacterial properties of AM-1155, a new 8-methoxy quinolone.
    Hosaka M, Kinoshita S, Toyama A, Otsuki M, Nishino T.
    J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
    Sader HS, Erwin ME, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):372-81. PubMed ID: 1327789
    [Abstract] [Full Text] [Related]

  • 30. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH, Reeves DS.
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [Abstract] [Full Text] [Related]

  • 31. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 32. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
    Ishii Y, Ohno A, Yamaguchi K.
    Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC, Bauriaud R, Gaubert E, Escaffre MC, Lareng MB.
    Chemotherapy; 1992 Jan; 38(5):303-7. PubMed ID: 1337506
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
    Felmingham D, Robbins MJ, Ingley K, Mathias I, Bhogal H, Leakey A, Ridgway GL, Grüneberg RN.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
    [Abstract] [Full Text] [Related]

  • 38. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Gooch G, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
    [Abstract] [Full Text] [Related]

  • 39. Respiratory pathogens: assessing resistance patterns in Europe and the potential role of grepafloxacin as treatment of patients with infections caused by these organisms.
    Felmingham D.
    J Antimicrob Chemother; 2000 Mar; 45():1-8. PubMed ID: 10719006
    [Abstract] [Full Text] [Related]

  • 40. Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia.
    Qadri SM, Abo-Askar H, Ueno Y.
    Chemotherapy; 1992 Mar; 38(2):92-8. PubMed ID: 1317281
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.